Thermo Fisher Scientific | TMO - Current Liabilities

Stock Price
469.71
Daily Change
3.01 0.64%
Monthly
-4.29%
Yearly
10.72%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $14.62B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agilent USD 2.23B 113M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.34B 62M Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
General Electric Aerospace USD 40.03B 1.05B Mar/2026
Henry Schein USD 3.23B 79M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Myriad Genetics USD 133.8M 14.2M Dec/2025
Olympus JPY 400.73B 106.59B Dec/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Quest Diagnostics USD 2.18B 101M Mar/2026
Repligen USD 135.83M 4.69M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veracyte USD 59.94M 12.22M Dec/2025
Waters USD 1.24B 11.8M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025